These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2875547)

  • 21. [Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
    Cappelli J; Morobe J; Van Laethem A; Musin L
    Acta Chir Belg; 1983; 83(6):440-3. PubMed ID: 6318487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 23. Famotidine 40mg B.I.D. in the treatment of reflux oesophagitis.
    Ahmed W; Qureshi H; Alam SE; Zuberi SJ
    J Pak Med Assoc; 1995 Sep; 45(9):241-3. PubMed ID: 8683830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cimetidine and other H2 receptor blockers].
    Pavlotzky M; Eschchar I; Neuman M
    Harefuah; 1978 Oct; 95(7):219-23. PubMed ID: 31319
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of reflux esophagitis].
    Berges W; Wienbeck M
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():15-7. PubMed ID: 7910994
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of H2 receptor antagonist with proton pump inhibitor is effective for long-term control of refractory reflux esophagitis.
    Adachi K; Komazawa Y; Mihara T; Fujishiro H; Ishihara S; Amano Y; Kinoshita Y
    J Clin Gastroenterol; 2004 Mar; 38(3):297-8. PubMed ID: 15128081
    [No Abstract]   [Full Text] [Related]  

  • 30. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of reflux oesophagitis.
    Wesdorp IC
    Scand J Gastroenterol Suppl; 1982; 79():106-19. PubMed ID: 6131532
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.
    Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y
    Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of severe reflux esophagitis.
    Richter JE
    Ann Intern Med; 1986 Apr; 104(4):588-9. PubMed ID: 2869728
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.
    Diebold MD; Richardson S; Duchateau A; Bigard MA; Colin R; Cortot A; Fauchère JL; Zeitoun P
    Dig Dis Sci; 1998 Aug; 43(8):1629-35. PubMed ID: 9724142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux in obesity: the effect of lap-band placement.
    Dixon JB; O'Brien PE
    Obes Surg; 1999 Dec; 9(6):527-31. PubMed ID: 10638476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of reflux esophagitis with ranitidine. A multicentric prospective study].
    Koelz HR; Birchler R; Bron B; Delmore G; Frey M; Gonvers JJ; Halter F; Hammer B; Miller G; Realini S; Blum AL
    Schweiz Med Wochenschr; 1982 Dec; 112(51):1901-4. PubMed ID: 6298933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple closure and follow up H2 receptor antagonists for perforated peptic ulcer--immediate survival and symptomatic outcome.
    Abbasakoor F; Attwood SE; McGrath JP; Stephens RB
    Ir Med J; 1995; 88(6):207-10. PubMed ID: 8575920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.